Medicenna Therapeutics Corp. (MDNAF) stock
MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Medicenna Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Medicenna Therapeutics's enterprise value was -$4.40M on Oct 19, 2026, against $48.51M a year earlier. Over the last 5 years it ranged from -$11.60M to $119.53M, with a median of $25.28M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | -$4.40M | -119.5% |
| 2025 | Dec 31, 2025 | $22.59M | -60.0% |
| 2024 | Dec 31, 2024 | $56.40M | – |
| 2023 | Dec 29, 2023 | -$4.21M | -140.8% |
| 2022 | Dec 30, 2022 | $10.31M | -83.8% |
| 2021 | Dec 31, 2021 | $63.51M | -68.4% |
| 2020 | Dec 31, 2020 | $201.23M | +177.7% |
| 2019 | Dec 31, 2019 | $72.47M | – |
See a number that looks wrong?